Abbott, MD+DI's 2017 Medtech Company of the Year, stood out from the rest not just because of its accomplishments and impact on patient care, but because of the leadership it showed in spite of the obstacles it faced along the way.
News & Features
MD+DI’s editors chose Abbott as the 2017 Medtech Company of the Year, but our readers had a different opinion.
Lionel Jeannin, fellow, global packaging & device development, Novartis Pharma AG, offers some insights on how partners can collaborate.
Georgia Tech released a new bionic hand designed to provide amputees with full hand dexterity and movement, right down to each individual finger.
An FDA advisory panel voted against recommending approval for Intrinsic Therapeutic's Barricaid prosthesis designed for partial annulus replacement in patients with herniated discs.
Smith & Nephew's MolecuLight iX is designed to detect bacteria in hard-to-heal wounds using only light.
The five-state settlement closes litigation over Medtronic's controversial Infuse bone graft device.
Virtual Incision raised $18 million in funding to support an FDA 510(k) submission for its miniaturized robotically assisted surgical device. Here's what sets this robotic device apart in an increasingly popular field.
Industry trade groups are applauding a House proposal to suspend the U.S. medical device tax for another five years, but the measure falls short of offering the industry a long-term solution.
NuVasive has agreed to acquire SafePassage, a provider of intraoperative neurophysiological monitoring services, for an undisclosed amount.
Unlike traditional DBS systems that are built from pacemaker technology, this device is modeled from cochlear implant technology and the precise stimulation of auditory nerves it uses to replicate hearing.